Pioneers Insight Method Research Author
Planet Microcap 2025 Q&A with Artem Fokin of Caro-Kann Capital
Back to Episodes

Planet Microcap 2025 Q&A with Artem Fokin of Caro-Kann Capital

Summary

  • Fokin argues that an investor should start by identifying the strongest relative skill in their toolkit and tailoring the process around it. He calls this comparative advantage an “investor superpower”; it need not be world-class, but the ideal is to tailor idea generation, research, and portfolio positions to it. He also links the superpower to what an investor loves doing and to who they are as a person.
  • A broken thesis should be diagnosed by testing its original premises against evidence, not by reacting to the share price. Fokin revisits notes and transcripts from six and 12 months earlier—“Do not rely on your memory”—then distinguishes management failure from temporary pressure and permanent structural change. If secular growth was essential and “the world is different,” leaving is probably appropriate.
  • Microcaps do not carry a mechanically higher return hurdle for Fokin, but they demand more conviction, closer management diligence, and explicit liquidity awareness. A $100 million company that becomes difficult to exit may effectively be a $50 million company; if execution instead takes it to $400 million–$700 million, exiting may become easier than initially building the position.
  • Developed-market microcaps can offer a better hunting ground because thinner venture and growth-equity ecosystems can bring promising businesses into public markets earlier. Walker explains that in the US, companies can stay private through Series A, B, C and “about 26 letters,” creating adverse selection for public microcap investors. Fokin says he needs only a handful of exceptional microcaps; Walker’s takeaway is that “saying no often is a good skill.”
  • Investing is a “mental sport” because research ultimately resolves into buy, sell, trim, add, and abstain decisions—and drawdowns can corrupt every one of them. Fokin says an investor either “had a drawdown,” is in one, or will have one; Walker’s sharper concern is whether selling reflects analysis or panic, and whether buying reflects opportunity or a YOLO attempt to recover losses.
  • Fokin’s safeguards are procedural and financial: trusted people who recognize tilt, acceptance that mistakes are unavoidable, and eventually a household buffer outside the fund. His view is that most personal capital should be invested in the fund, while his thinking has evolved toward holding one to three years of living expenses in cash equivalents. He candidly says he has not yet established that reserve himself.

Deep dive

1. An investor’s superpower should determine where they swing

  • Fokin defines an investor’s superpower as comparative advantage: one skill or trait that is stronger than everything else in that person’s toolkit. The ideal outcome is to “tailor the idea generation, research and positions in the portfolio to that superpower.”

  • His Kasparov analogy separates absolute competence from relative edge. A world chess champion is strong everywhere, yet particular board positions better fit his style and personality; similarly, an investor’s best arena is usually linked to “what you love doing and to you as a person.”

  • Fokin’s own edge is matching a conceptual business-model framework with evidence gathered from dispersed sources. For one unnamed holding, he reviewed about 70 expert calls, conducted roughly 10 himself and later said the total had grown to probably about 95—but insists, “It’s not about reading per se. It’s about extracting information and putting that information into the right buckets.”

  • That company also illustrates thesis evolution: Fokin had heard two earlier theses, then encountered a “third generation of the thesis” on Walker’s podcast. He subsequently built the historical model, read earnings calls and moved into extensive expert work.

2. Selling requires reconstructing the thesis, not trusting memory

  • Fokin offers “no silver bullet” for distinguishing a bad quarter from a broken business. His most useful discipline is rereading management notes and earnings- and conference-call transcripts from six and 12 months earlier, then comparing promises with outcomes: “Do not rely on your memory and your own recall.”

  • The evidence tree matters. Was management simply unable to execute, or did the external environment change? If the change is temporary, holding may be justified; if it is permanent and the thesis depended on secular growth, “the world is different” and it is probably time to leave.

  • Walker supplies the uncomfortable specimen: management first promised an outcome that year, later pushed it into the next, and two years afterward it remained perpetually six months away. He said that, if he was being honest with himself, he would have concluded the thesis had broken 18 months earlier, but kept “waiting and hoping.”

  • Fokin recently reversed course on an unnamed company of roughly $2 billion market capitalization after only two months. The thesis had three or four premises, and strong evidence showed that at least two or three were no longer valid; although conditions might change, he believed the company had already received ample leeway over the preceding 12 months.

3. Microcap risk hides in people, execution ceilings, and the exit door

  • Smaller businesses deserve some additional operating leeway because they have fewer people and resources, but “that leeway cannot be infinite.” A management team that successfully scaled revenue from $1 million to $10 million and then $50 million may have reached the ceiling of its natural abilities.

  • Walker’s pushback is that an apparent management ceiling may really be a TAM or market-structure ceiling. Fokin declines to generalize: the cleanest test is whether a replacement team with experience running larger businesses can grow the company; if it cannot, the constraint was probably the industry, market share or business itself.

  • Management access matters more in microcaps because investors cannot assume depth behind the CEO and CFO. At companies worth $2 billion–$5 billion, Fokin considers it safer to expect capable replacements; in a microcap, understanding the bench requires direct and more frequent diligence.

  • Liquidity changes the risk calculus rather than mechanically raising Fokin’s return requirement. “I need more conviction in the microcap idea,” because entering a $100 million company can be easy while exiting after it has effectively become a $50 million company can be “very, very difficult.” If fundamentals instead take it to $400 million, $500 million or $700 million, exiting may be easier than building the position initially.

4. Developed-market microcaps can escape America’s private-market filter

  • Fokin avoids emerging-market microcaps and models currency depreciation when a portfolio company operates in a currency that has historically depreciated against the US dollar. He is more comfortable buying microcaps in developed markets outside the US, where venture capital and growth equity are “massively less developed.”

  • Walker’s causal argument is that abundant US private capital lets strong companies remain private through repeated rounds. “There are about 26 letters in the English alphabet,” he jokes, so companies can postpone public listing for years and leave public microcap investors facing adverse selection.

  • Fokin says he is not that worried because his goal is not to find 300 amazing microcaps; it is to find a handful. Walker presses the game-selection problem: if 290 of 300 available companies are poor, finding the exceptional 10 may be inferior to searching a healthier pool. Walker also notes that “saying no often is a good skill.” Fokin attributes the distortion more to 15 years of venture fundraising than to Sarbanes-Oxley compliance costs.

5. Drawdown resilience requires both psychological and financial slack

  • Against an April 22 backdrop of the Russell down roughly 15% year to date—and about 20% over four months in Walker’s earlier framing—Fokin calls investing a mental sport. Research ultimately leads to portfolio decisions, and “whether you go on tilt or not” becomes decisive.

  • Walker identifies the drawdown trap: selling can be either sober thesis reassessment or fear, while adding can be either rational opportunity capture or a YOLO bid to recover. He has seen investors increase portfolio variance with companies they would never have owned absent recent losses.

  • Fokin’s procedural answer is a coach or trusted peer group that understands both the investor’s psychology and the kinds of investments where they historically win or lose. Journaling may help, but he doubts many people will consult it “in the heat of battle” and diagnose their own tilt.

  • His resilience model is Kasparov’s 1984 match against Anatoly Karpov, who had a lot of support from the Soviet government. Down 5–0 in a first-to-six contest—“Nobody should be able to come back”—Kasparov recovered to 5–3 before the match was interrupted for reasons Fokin said could only be speculated about, then later won the next match. The lesson is that greatness can coexist with severe failure and recovery.

  • Financial pressure compounds the mental game because small and emerging managers often have both income and most of their net worth tied to their funds. Fokin’s view is that most personal capital should be invested in the fund, while his thinking has evolved toward holding one to three years of expenses in cash equivalents; an uncorrelated spouse’s income can also provide useful household diversification. He says he does not currently have that reserve.